Mayo Clinic Laboratory and Pathology Research Roundup: May 7

By Sarah Jarvis • May 7, 2024

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

CoaguChek and Coag-Sense PT2 meter point of care INR device validation.

To standardize international normalized ratio (INR) measurements and improve data integrity by enabling electronic result transmission for warfarin monitoring, two point-of-care (POC) devices were evaluated against an internal plasma INR reference method.

Read more.

Published to PubMed This Week

• Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.
  Biomarkers
• Induction of p16Ink4a gene expression in heme protein-induced AKI and by heme: Pathophysiologic implications.
  Kidney360
• Expanded access to video-based laparoscopic skills assessments: Ease, reliability, and accuracy.
  Journal of Surgical Education
• Expanding the spectrum of paratesticular mullerian-origin tumors: Adenocarcinoma with mixed serous and endometrioid features and clear cell carcinoma.
  Human Pathology
• ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner.
  Human Pathology
• Detection and quantification of Babesia species intraerythrocytic parasites by flow cytometry.
  American Journal of Clinical Pathology
• A narrative review of telemedicine and its adoption across specialties.
  mHealth
• Diagnostic pitfalls: Florid mesothelial hyperplasia and mesothelioma of the tunica vaginalis.
  Human Pathology

Sarah Jarvis

Sarah Jarvis is a Senior Marketing Specialist at Mayo Clinic Laboratories. She supports marketing strategies for paid media.